Wikipedia -WSS

Wikipedia

author：focus 2025-09-28 23:49:13 - browse：7826

Adam's take main illustration — Molly Ferguson/STAT

The Food and Drug Administration should halt Cassava Sciences’ ongoing clinical trials in Alzheimer’s disease. That, and other thoughts on the fallout from the City University of New York investigation that raised serious doubts about the science underpinning the company’s experimental drug simufilam.

Patient safety is paramount to the FDA, so stopping Cassava’s two Phase 3 studies is the ethically correct thing to do.The FDA has the power to place clinical holds on experimental drugs when there’s evidence of an unacceptable safety risk to study participants. Simufilam doesn’t appear to be toxic. It’s not causing dangerous side effects. But study participants can also be harmed when they volunteer for a clinical trial based on false or misleading information about a drug’s potential efficacy.

The CUNY committee charged with investigating Cassava’s principal scientific collaborator, the neuroscientist Hoau-Yan Wang, could not definitively prove that Wang faked simufilam data, but that’s only because he refused to turn over original data and primary research records that the committee had requested to examine. Wang also claimed that boxes of research records relevant to the investigation were thrown away. The investigative report was first made public last week in the journal Science.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Shionogi licenses Pompe disease therapy from Maze Therapeutics

explore

WSS

Telehealth startups turn to complex chronic diseases

What causes osteoarthritis? Researchers study link to brain protein

Pumping milk in bathrooms at health conferences is common

Future doctors need a strong humanities education

Flu vaccine reformulation won't be easy, manufacturers warn

Software glitch causes Tandem insulin pump to shutdown, FDA warns

focus

Wikipedia

explore

Duchenne breakthrough therapy leaves behind pioneering families

Software glitch causes Tandem insulin pump to shutdown, FDA warns

Affirmative action in medical school literally saved lives

Inaction leaves children at risk from dangerous chemotherapy drug

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Readout LOUD podcast: brain research, obesity drug sales, Novartis

Wildfire smoke exposes gaps in outdoor worker protections

Cardiologists urge adding sexual orientation, gender identity to health records

After affirmative action ruling, medical educators look to 'holistic review'

How to improve immunocompromised access to mAb treatments

leisure time

The inclusion problem at the heart of rehabilitation research

TikTok, Instagram influencers need more rules for drug ads

High breast density mammograms need follow

Elevance, private equity launch primary care company

Software glitch causes Tandem insulin pump to shutdown, FDA warns

Telehealth startups turn to complex chronic diseases

focus

explore

explore

entertainment